ch commercial Pathway through a=backdoor? Source: Cartoonstock 0This week Osiris Therapeuti=s Inc. (OSIR - $19.76 - NR) demonstrated the utility of Grafix, the compan='s allogeneic product for diabetic foot ulcers (DFU), long a grave=ard of failed therapies. Grafix, is a 3D cellular matrix comprising